Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 5090  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
 »   Next article
 »   Previous article
 »   Table of Contents

 Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded99    
    Comments [Add]    
    Cited by others 3    

Recommend this journal


Year : 2014  |  Volume : 62  |  Issue : 1  |  Page : 48--52

A Markov model to compare the long-term effect of aspirin, clopidogrel and clopidogrel plus aspirin on prevention of recurrent ischemic stroke due to intracranial artery stenosis

1 Medical College, The Wang Yanan Institute for Studies in Economics, Xiamen University, Fujian, China
2 Department of Neurosurgery, Zhongda Hospital, Southeast University, Nanjing, China
3 Department of Neurosurgery, NASA Neuro Care, Jalandhar, Punjab, India
4 Guangdong Landau Biotechnology Co. Ltd., Guangzhou, China

Correspondence Address:
Lukui Chen
Department of Neurosurgery, Zhongda Hospital Southeast University, Nanjing
Login to access the Email id

Source of Support: National Science and Technology Major Project of Key Drug Innovation and Development (2011ZX09307-303-03), Conflict of Interest: None

DOI: 10.4103/0028-3886.128290

Rights and Permissions

Background: Given the importance of intracranial stenosis as a cause of recurrent ischemic stroke and the lack of evidence supporting a clear choice for prevention of recurrent ischemic events, a computer simulation model for prognostic prediction could be used to improve decision making. Aims: The aim of the following study is to compare the long-term effect of aspirin, clopidogrel and clopidogrel plus aspirin for prevention of recurrent stroke due to atherosclerotic intracranial artery stenosis. Setting and Design: The cohort consisted of 206 patients from 2006 to 2011. Materials and Methods: A two-state Markov model was used to predict the prognosis of patients with stroke or transient ischemic attack (TIA) caused by angiographically verified 50-99% stenosis of a major intracranial artery to receive aspirin, clopidogrel, or dual therapy. Statistical Analysis: Two tests were used: Pearson Chi-square test or Fisher's exact test (for percentages) and Kruskal Wallis test (for rank order data). Results: In the 10-year Markov cohort analysis, 36.24% of patients who were treated with clopidogrel plus aspirin developed to recurrent stroke while the probability for patients in the aspirin group and clopidogrel group was 42.60% and 48.39% respectively. Patients with clopidogrel plus aspirin had the highest quality-adjusted life years, followed by aspirin and clopidogrel. Conclusion: To prevent recurrent stroke in patients with intracranial artery stenosis, especially in those patients with a history of TIA or coronary artery disease, medical therapy with clopidogrel plus aspirin should be considered in preference to aspirin alone.


Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow